A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Recruiting now · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Focal Epilepsy

In brief

The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.

Key facts

Study ID
NCT06132893
Run by
Biohaven Therapeutics Ltd.
People needed
390
Starts
2024-03-14
Expected to finish
2026-12-01
Last updated by the study team
2026-05-01

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.